SWK Holdings Corporation (SWKH)

NASDAQ: SWKH · IEX Real-Time Price · USD
17.36
+0.02 (0.12%)
Apr 19, 2024, 9:30 AM EDT - Market open
0.12%
Market Cap 216.95M
Revenue (ttm) 37.76M
Net Income (ttm) 15.89M
Shares Out 12.50M
EPS (ttm) 1.25
PE Ratio 13.87
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 478
Open 17.36
Previous Close 17.34
Day's Range 17.36 - 17.36
52-Week Range 15.26 - 18.75
Beta 0.33
Analysts n/a
Price Target n/a
Earnings Date May 9, 2024

About SWKH

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to... [Read more]

Sector Financials
IPO Date Sep 22, 1999
Employees 23
Stock Exchange NASDAQ
Ticker Symbol SWKH
Full Company Profile

Financial Performance

In 2023, SWK Holdings's revenue was $37.76 million, a decrease of -8.98% compared to the previous year's $41.48 million. Earnings were $15.89 million, an increase of 17.76%.

Financial Statements

News

SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023

Conference Call and Live Audio Webcast Scheduled for Thursday, March 21, 2024, at 10:00 a.m. ET Corporate Highlights Fourth quarter 2023 and 2022 net income was $2.8 million Full year 2023 net income ...

4 weeks ago - Accesswire

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

DALLAS, TX / ACCESSWIRE / January 23, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercia...

3 months ago - Accesswire

SWK Holdings Corporation Announces Financial Results for Third Quarter 2023

Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET Corporate Highlights Third quarter of 2023 GAAP net income was $4.5 million or $0.36 per diluted share...

5 months ago - PRNewsWire

SWK Holdings Corporation to Report Third Quarter 2023 Financial Results

Conference Call and Live Audio Webcast Scheduled for  Thursday, November 9, 2023, at 10:00 a.m. ET DALLAS , Nov. 6, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"...

5 months ago - PRNewsWire

SWK Holdings Corporation Announces B. Riley Securities Exercises Option to Purchase Approximately $3 Million in Additional Unsecured Senior Notes

DALLAS , Oct. 30, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that B. Riley Securities has exercised its option to purchase $2,968,750 in addi...

6 months ago - PRNewsWire

SWK Holdings Corporation Increases Revolving Credit Facility to $60 Million

DALLAS , Oct. 11, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life-science-focused, specialty finance company catering to small- and mid-sized commercial-s...

6 months ago - PRNewsWire

SWK Holdings Corporation Announces Closing of Public Offering of Senior Unsecured Notes Due 2027

DALLAS , Oct. 3, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it has completed its previously announced registered underwritten public off...

7 months ago - PRNewsWire

SWK Holdings Corporation Announces Pricing of Public Offering of Senior Unsecured Notes Due 2027

DALLAS , Sept. 28, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it has priced its previously announced registered underwritten public offe...

7 months ago - PRNewsWire

SWK Holdings Corporation Announces Public Offering of Senior Unsecured Notes Due 2028

DALLAS , Sept. 26, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it plans to offer $30 million in aggregate principal amount of senior unse...

7 months ago - PRNewsWire

SWK Holdings Corporation Announces Financial Results for Second Quarter 2023

Conference Call and Live Audio Webcast Scheduled for Wednesday, August 9, 2023, at 5:00 p.m. ET Corporate Highlights Second quarter 2023 GAAP net income was $3.9 million or $0.31 per diluted share, co...

9 months ago - PRNewsWire

SWK Holdings Corporation to Report Second Quarter 2023 Financial Results

Conference Call and Live Audio Webcast Scheduled for Wednesday, August 9, 2023, at 5:00 p.m. ET DALLAS , Aug. 8, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), ...

9 months ago - PRNewsWire

SWK Holdings Corporation Announces New Credit Facility with $45 Million Committed at Close

DALLAS , June 28, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-st...

10 months ago - PRNewsWire

SWK Holdings Corporation Announces Financial Results for First Quarter 2023

Conference Call and Live Audio Webcast Scheduled for Thursday, May 11, 2023, at 10:00 a.m. ET Corporate Highlights First quarter 2023 GAAP net income was $4.6 million or $0.36 per diluted share, compa...

1 year ago - PRNewsWire

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full Year 2022

Conference Call and Live Audio Webcast Scheduled for Today, April 3, 2023, at 10:00 a.m. ET Corporate Highlights Jody Staggs named President and Chief Executive Officer Appointed Laurie Dotter as Chai...

1 year ago - PRNewsWire

SWK Holdings Corporation to Report Fourth Quarter and Full-Year 2022 Financial Results

Conference Call and Live Audio Webcast Scheduled for Monday, April 3, 2023, at 10:00 a.m. ET DALLAS , March 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a...

1 year ago - PRNewsWire

SWK Holdings Appoints Jerry Albright to Board of Directors

DALLAS , March 15, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-s...

1 year ago - PRNewsWire

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

Fourth Quarter and Full Year 2022 Financial Results to be Announced in March DALLAS , Jan. 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-foc...

1 year ago - PRNewsWire

SWK Holdings Names Jody Staggs Chief Executive Officer and Appoints Laurie Dotter as Chair of the Board

Mr. Staggs elevated from "interim" to "permanent" CEO as SWK advances multiple initiatives in 2023 Ms. Dotter joined SWK's Board of Directors in February 2022 DALLAS , Jan. 3, 2023 /PRNewswire/ -- SWK...

1 year ago - PRNewsWire

SWK Holdings Corporation Announces Upsizing of Credit Facility up to $50 Million

DALLAS , Nov. 16, 2022 /PRNewswire/ -- SW K Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-s...

1 year ago - PRNewsWire

SWK Holdings Corporation Announces Financial Results for Third Quarter 2022

Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET Corporate Highlights Successful leadership transition with Jody Staggs named President and Interim Ch...

1 year ago - PRNewsWire

SWK Holdings Corporation to Report Third Quarter 2022 Financial Results

Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET DALLAS , Nov. 8, 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company"...

1 year ago - PRNewsWire

Enteris BioPharma Presents Study of Ovarest® Demonstrating Oral Delivery Comparable to or Exceeding Injectable Leuprolide

Oral Presentation Delivered at the American Society for Reproductive Medicine Scientific (ASRM) 2022 Congress & Expo BOONTON, N.J. , Oct. 26, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnol...

1 year ago - PRNewsWire

SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics

Milestone payment highlights ongoing clinical progress of Oral KORSUVA™ DALLAS , Oct. 10 2022  /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance compan...

Other symbols: CARA
1 year ago - PRNewsWire

SWK Holdings Enhances Executive Management Team and Expands Underwriting Team

Yvette Heinrichson promoted to Chief Financial Officer John David Tamas promoted to Director of Underwriting DALLAS , Oct. 3, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the...

1 year ago - PRNewsWire

Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides

Physicochemical properties of peptides can provide key insights to potential success of oral delivery BOONTON, N.J. , Sept. 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company de...

1 year ago - PRNewsWire